This is the most important poster ATH has in the meeting because it deals with PD, most likely the next human study of ATH. In fact, MPTP model is a human model, as has been explained and it works also in primates. The positive results are very valuable and should be in the interests of big pharma. How to make the poster for this purpose is a big challenge but equally, it should also interest M Fox Foundation ( more money for ATH ???)
This is the most important poster ATH has in the meeting because...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $2.523K | 504.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 37015203 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 20752393 | 17 |
View Market Depth
| Last trade - 10.35am 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.6¢ | 0.6¢ | 0.5¢ | 1100000 | ||
| Last updated 10.51am 17/05/2024 ? | |||||
| ATH (ASX) Chart |